ArticleCancer letters2022
DNMT and EZH2 inhibitors synergize to activate therapeutic targets in hepatocellular carcinoma.
Lian Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
40 papers cite it
this papercites it
ArticleCancer letters2022
Lian Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.